Literature DB >> 29192238

Evaluation of reported pathogenic variants and their frequencies in a Japanese population based on a whole-genome reference panel of 2049 individuals.

Yumi Yamaguchi-Kabata1,2, Jun Yasuda3,4, Osamu Tanabe3,4, Yoichi Suzuki3,4,5, Hiroshi Kawame3,4, Nobuo Fuse3,4, Masao Nagasaki3,4,6, Yosuke Kawai3,4, Kaname Kojima3,4, Fumiki Katsuoka3,4, Sakae Saito3,4, Inaho Danjoh3,4, Ikuko N Motoike3,4,6, Riu Yamashita3,4,6, Seizo Koshiba3,4, Daisuke Saigusa3,4, Gen Tamiya3,4,7, Shigeo Kure3,4, Nobuo Yaegashi3,4, Yoshio Kawaguchi3, Fuji Nagami3, Shinichi Kuriyama3,4,8, Junichi Sugawara3,4, Naoko Minegishi3,4, Atsushi Hozawa3,4, Soichi Ogishima3,4, Hideyasu Kiyomoto3,4,9, Takako Takai-Igarashi3,4, Kengo Kinoshita10,11,12, Masayuki Yamamoto3,4.   

Abstract

Clarifying allele frequencies of disease-related genetic variants in a population is important in genomic medicine; however, such data is not yet available for the Japanese population. To estimate frequencies of actionable pathogenic variants in the Japanese population, we examined the reported pathological variants in genes recommended by the American College of Medical Genetics and Genomics (ACMG) in our reference panel of genomic variations, 2KJPN, which was created by whole-genome sequencing of 2049 individuals of the resident cohort of the Tohoku Medical Megabank Project. We searched for pathogenic variants in 2KJPN for 57 autosomal ACMG-recommended genes responsible for 26 diseases and then examined their frequencies. By referring to public databases of pathogenic variations, we identified 143 reported pathogenic variants in 2KJPN for the 57 ACMG recommended genes based on a classification system. At the individual level, 21% of the individuals were found to have at least one reported pathogenic allele. We then conducted a literature survey to review the variants and to check for evidence of pathogenicity. Our results suggest that a substantial number of people have reported pathogenic alleles for the ACMG genes, and reviewing variants is indispensable for constructing the information infrastructure of genomic medicine for the Japanese population.

Entities:  

Mesh:

Year:  2017        PMID: 29192238     DOI: 10.1038/s10038-017-0347-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  77 in total

1.  Evolution and functional impact of rare coding variation from deep sequencing of human exomes.

Authors:  Jacob A Tennessen; Abigail W Bigham; Timothy D O'Connor; Wenqing Fu; Eimear E Kenny; Simon Gravel; Sean McGee; Ron Do; Xiaoming Liu; Goo Jun; Hyun Min Kang; Daniel Jordan; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; Goncalo Abecasis; David Altshuler; Deborah A Nickerson; Eric Boerwinkle; Shamil Sunyaev; Carlos D Bustamante; Michael J Bamshad; Joshua M Akey
Journal:  Science       Date:  2012-05-17       Impact factor: 47.728

2.  Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.

Authors:  M Cravo; A J Afonso; P Lage; C Albuquerque; L Maia; C Lacerda; P Fidalgo; P Chaves; C Cruz; C Nobre-Leitão
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

3.  The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulation.

Authors:  Tohru Noguchi; Shoji Katsuda; Masa-Aki Kawashiri; Hayato Tada; Atsushi Nohara; Akihiro Inazu; Masakazu Yamagishi; Junji Kobayashi; Hiroshi Mabuchi
Journal:  Atherosclerosis       Date:  2009-11-20       Impact factor: 5.162

4.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

Authors:  Marianne Abifadel; Mathilde Varret; Jean-Pierre Rabès; Delphine Allard; Khadija Ouguerram; Martine Devillers; Corinne Cruaud; Suzanne Benjannet; Louise Wickham; Danièle Erlich; Aurélie Derré; Ludovic Villéger; Michel Farnier; Isabel Beucler; Eric Bruckert; Jean Chambaz; Bernard Chanu; Jean-Michel Lecerf; Gerald Luc; Philippe Moulin; Jean Weissenbach; Annick Prat; Michel Krempf; Claudine Junien; Nabil G Seidah; Catherine Boileau
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

5.  Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.

Authors:  Pedro A Lage; Cristina Albuquerque; Rita G Sousa; Marilia L Cravo; Maria Salazar; Inês Francisco; Lara Maia; Isabel Claro; Alexandra Suspiro; Paula Rodrigues; Hélder Raposo; Paulo A Fidalgo; Carlos Nobre-Leitão
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

6.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

7.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.

Authors:  Sarah S Kalia; Kathy Adelman; Sherri J Bale; Wendy K Chung; Christine Eng; James P Evans; Gail E Herman; Sophia B Hufnagel; Teri E Klein; Bruce R Korf; Kent D McKelvey; Kelly E Ormond; C Sue Richards; Christopher N Vlangos; Michael Watson; Christa L Martin; David T Miller
Journal:  Genet Med       Date:  2016-11-17       Impact factor: 8.822

8.  Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics.

Authors:  Julie Jurgens; Hua Ling; Kurt Hetrick; Elizabeth Pugh; Francois Schiettecatte; Kimberly Doheny; Ada Hamosh; Dimitri Avramopoulos; David Valle; Nara Sobreira
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

9.  Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants.

Authors:  Wenqing Fu; Timothy D O'Connor; Goo Jun; Hyun Min Kang; Goncalo Abecasis; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; David Altshuler; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Joshua M Akey
Journal:  Nature       Date:  2012-11-28       Impact factor: 49.962

10.  The UK10K project identifies rare variants in health and disease.

Authors:  Klaudia Walter; Josine L Min; Jie Huang; Lucy Crooks; Yasin Memari; Shane McCarthy; John R B Perry; ChangJiang Xu; Marta Futema; Daniel Lawson; Valentina Iotchkova; Stephan Schiffels; Audrey E Hendricks; Petr Danecek; Rui Li; James Floyd; Louise V Wain; Inês Barroso; Steve E Humphries; Matthew E Hurles; Eleftheria Zeggini; Jeffrey C Barrett; Vincent Plagnol; J Brent Richards; Celia M T Greenwood; Nicholas J Timpson; Richard Durbin; Nicole Soranzo
Journal:  Nature       Date:  2015-09-14       Impact factor: 49.962

View more
  14 in total

1.  Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.

Authors:  Yasue Horiuchi; Hiroyuki Matsubayashi; Yoshimi Kiyozumi; Seiichiro Nishimura; Satomi Higashigawa; Nobuhiro Kado; Takeshi Nagashima; Maki Mizuguchi; Sumiko Ohnami; Makoto Arai; Kenichi Urakami; Masatoshi Kusuhara; Ken Yamaguchi
Journal:  Hum Genet       Date:  2020-07-24       Impact factor: 4.132

2.  Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar.

Authors:  Abhinav Jain; Shrey Gandhi; Remya Koshy; Vinod Scaria
Journal:  Mol Genet Genomics       Date:  2018-03-20       Impact factor: 3.291

3.  Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).

Authors:  Hideki Tokunaga; Keita Iida; Atsushi Hozawa; Soichi Ogishima; Yoh Watanabe; Shogo Shigeta; Muneaki Shimada; Yumi Yamaguchi-Kabata; Shu Tadaka; Fumiki Katsuoka; Shin Ito; Kazuki Kumada; Yohei Hamanaka; Nobuo Fuse; Kengo Kinoshita; Masayuki Yamamoto; Nobuo Yaegashi; Jun Yasuda
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

4.  Interpretation of Incidental Genetic Findings Localizing to Genes Associated With Cardiac Channelopathies and Cardiomyopathies.

Authors:  Jordan E Ezekian; Catherine Rehder; Priya S Kishnani; Andrew P Landstrom
Journal:  Circ Genom Precis Med       Date:  2021-08-13

5.  Tensions in ethics and policy created by National Precision Medicine Programs.

Authors:  Jusaku Minari; Kyle B Brothers; Michael Morrison
Journal:  Hum Genomics       Date:  2018-04-17       Impact factor: 4.639

6.  Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance.

Authors:  Hitoshi Nagura; Jiro Hokugo; Kazuo Ueda
Journal:  Neurol Ther       Date:  2019-09-26

7.  The return of individual genomic results to research participants: design and pilot study of Tohoku Medical Megabank Project.

Authors:  Hiroshi Kawame; Akimune Fukushima; Nobuo Fuse; Fuji Nagami; Yoichi Suzuki; Mika Sakurai-Yageta; Jun Yasuda; Yumi Yamaguchi-Kabata; Kengo Kinoshita; Soichi Ogishima; Takako Takai; Shinichi Kuriyama; Atsushi Hozawa; Naoki Nakaya; Tomohiro Nakamura; Naoko Minegishi; Junichi Sugawara; Kichiya Suzuki; Hiroaki Tomita; Akira Uruno; Tomoko Kobayashi; Yayoi Aizawa; Tomoharu Tokutomi; Kayono Yamamoto; Kinuko Ohneda; Shigeo Kure; Yoko Aoki; Hideki Katagiri; Yasushi Ishigaki; Shojiro Sawada; Makoto Sasaki; Masayuki Yamamoto
Journal:  J Hum Genet       Date:  2021-07-08       Impact factor: 3.172

8.  GATA4 variant identified by whole-exome sequencing in a Japanese family with atrial septal defect: Implications for male sex development.

Authors:  Daisuke Shimizu; Satoru Iwashima; Keisuke Sato; Satoshi Hayano; Maki Fukami; Hirotomo Saitsu; Tsutomu Ogata
Journal:  Clin Case Rep       Date:  2018-10-11

9.  Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.

Authors:  Yoshimi Kiyozumi; Hiroyuki Matsubayashi; Yasue Horiuchi; Satomi Higashigawa; Takuma Oishi; Masato Abe; Sumiko Ohnami; Kenichi Urakami; Takeshi Nagashima; Masatoshi Kusuhara; Hidehiko Miyake; Ken Yamaguchi
Journal:  Cancer Med       Date:  2019-08-06       Impact factor: 4.452

10.  Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes.

Authors:  Chieh-Wen Kuo; Wuh-Liang Hwu; Yin-Hsiu Chien; Ching Hsu; Miao-Zi Hung; I-Lin Lin; Feipei Lai; Ni-Chung Lee
Journal:  Mol Genet Genomic Med       Date:  2020-08-14       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.